Zai Lab Ltd

Research Zai Lab Ltd (ZLAB) on Bullrun: market cap USD 2.04B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZLAB
• ExchangeNASDAQ
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.04B
• Financial periodFY2025
• RevenueUSD 457.18M
• Revenue growth15.0%
• Net income-USD 175.50M
• Free cash flow-USD 158.89M
• Gross margin58.3%

Valuation Snapshot

latest market cap is USD 2.04B.

About Zai Lab Ltd

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy;

Frequently asked questions

What is Zai Lab Ltd's market cap?

Zai Lab Ltd's market capitalization is USD 2.04B.

What does Zai Lab Ltd do?

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.